HARP - Harpoon Therapeutics GAAP EPS of -$0.53 beats by $0.03 revenue of $8.3M beats by $1.34M August, 10 2022 04:50 PM Harpoon Therapeutics Inc. Harpoon Therapeutics press release ( NASDAQ: HARP ): Q2 GAAP EPS of -$0.53 beats by $0.03 . Revenue of $8.3M (+43.1% Y/Y) beats by $1.34M . For further details see: Harpoon Therapeutics GAAP EPS of -$0.53 beats by $0.03, revenue of $8.3M beats by $1.34M